[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368227-105":59,"doc-detail-368227-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-pan-cancer-analysis-of-enoph1-in-human-tumors","Comprehensive pan-cancer analysis of ENOPH1 in human tumors","","Pan-cancer analysis of ENOPH1 (Enolase-phosphatase 1) is presented to clarify its underexplored role in tumorigenesis. Using UCSC-derived expression data, GEPIA2 and cBioPortal for survival, alterations, and RNA modification links, and TIMER2 plus R for immune infiltration, TMB, MSI, and HRD, the study evaluates associations across multiple cancer types. Results identify increased ENOPH1 expression, prognostic relevance, and pathway connections.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-pan-cancer-analysis-of-enoph1-in-human-tumors/368227/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-pan-cancer-analysis-of-enoph1-in-human-tumors/368227.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of this pan-cancer analysis of ENOPH1?","Question",{"text":112,"@type":113},"The study aims to elucidate ENOPH1’s role across multiple cancers by analyzing expression, survival associations, genetic alterations, RNA modifications, and links to immune and genomic features.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which platforms and data resources were used to assess ENOPH1 in tumors?",{"text":117,"@type":113},"The analysis uses UCSC databases for expression evaluation, GEPIA2 and cBioPortal for survival, genetic alterations, and RNA modification-related assessment, and TIMER2 with R for immune infiltration, TMB, MSI, and HRD.",{"name":119,"@type":110,"acceptedAnswer":120},"What major findings relate ENOPH1 to cancer prognosis and molecular features?",{"text":121,"@type":113},"ENOPH1 is upregulated in multiple cancers and high expression correlates with worse overall and disease-specific survival in several tumor types. It also shows correlations with RNA modifications, immune checkpoints/modulators, and genomic instability measures such as TMB, MSI, and HRD.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368227,1790439820,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Analysis  \nComprehensive pan‑cancer analysis of ENOPH1 in human tumors  \nXuezhong Zhang1,2,3 · Ning Li4 · Tingting Chu2 · Haijun Zhao1 · Tonggang Liu5  \nReceived: 12 October 2024 / Accepted: 10 February 2025  \n© The Author(s) 2025 OPEN  \nAbstract  \nBackground ENOPH1 (Enolase-phosphatase 1), a member of the HAD-like hydrolase superfamily, has been linked to a range of physiological conditions, including neurological disorders. However, its involvement in tumorigenesis remains underexplored. This study is the first to conduct a pan-cancer analysis of ENOPH1, aiming to elucidate its role in multiple cancers through various bioinformatics platforms.  \nMethods We conducted a thorough analysis using data from UCSC databases. ENOPH1 expression in tumor and normal tissues was evaluated using R language software. Survival analyses, genetic alterations, and RNA modifications were assessed through the GEPIA2 and cBioPortal platforms. The relationships between ENOPH1 and immune infiltration, tumor mutational burden (TMB), microsatellite instability (MSI), and homologous recombination deficiency (HRD) were examined using TIMER2 and R software. ENOPH1-related gene enrichment analysis was performed using the STRING and GEPIA2 databases, followed by Gene Ontology (GO) and KEGG pathway enrichment analyses.  \nResults ENOPH1 expression was significantly upregulated in various cancers, including ACC, BLCA, BRCA, and COAD. High ENOPH1 expression was associated with poor overall survival (OS) in cancers such as KICH, LIHC, BRCA and LUAD. High ENOPH1 expression was associated with poor disease specific survival (DSS) in cancers such as KICH, LIHC, BRCA and MESO. Genetic alterations of ENOPH1, primarily mutations and deep deletions, were identified in UCEC, BLCA, and OV. ENOPH1 showed significant correlations with RNA modifications (m1A, m5C, m6A), immune checkpoints, and immune modulators across multiple cancer types. ENOPH1 was positively correlated with TMB, MSI, and HRD in cancers like BLCA, BRCA, and STAD. Furthermore, enrichment analysis revealed that ENOPH1 interacts with proteins involved in critical pathways such as AMPK, Hippo, and PI3K-AKT, suggesting its role in cancer progression.  \nConclusion This pan-cancer analysis reveals ENOPH1’s potential as a prognostic biomarker and its involvement in key signaling pathways across multiple cancers. Our findings provide new insights into the role of ENOPH1 in tumorigenesis and highlight its potential as a therapeutic target in cancer treatment.  \nKeywords ENOPH1 · Prognostic biomarker · Pan-cancer · Tumors  \nXuezhong Zhang, Ning Li, Tingting Chu have share first authorship.  \nSupplementary Information The online version contains supplementary material available at [https://doi.org/10.1007/s12672-025-](https://doi.org/10.1007/s12672-025-)[ ](https://doi.org/10.1007/s12672-025-)[01965-x](01965-x.)[.](01965-x.)  \n* Haijun Zhao, [haijunzhao@sdutcm.edu.cn](haijunzhao@sdutcm.edu.cn); * Tonggang Liu, [liutonggang123@126.com |](liutonggang123@126.com |1College of Traditional Chinese Medicine)[1](liutonggang123@126.com |1College of Traditional Chinese Medicine)[College of Traditional Chinese Medicine](liutonggang123@126.com |1College of Traditional Chinese Medicine), Shandong University of Traditional Chinese Medicine, Jinan, China. 2Department of Laboratory Medicine, Zibo Central Hospital, Zibo, Shandong, China. 3Shandong Jincheng Pharmaceutical Group Co., Ltd., Zibo, Shandong, China. 4Department of Pulmonary and Critical Care Medicine, Zibo Central Hospital, Zibo, Shandong, China. 5Department of Infectious Diseases, Binzhou Medical University Hospital, Binzhou, Shandong, China.  \nDiscover Oncology  \n(2025) 16:190  \n| [https://doi.org/10.1007/s12672-025-01965-x](https://doi.org/10.1007/s12672-025-01965-x)  \nAbbreviations  \nACC Adrenocortical carcinoma BLCA Bladder urothelial carcinoma BRCA Breast invasive carcinoma  \nCESC Cervical squamous cell carcinoma and endocervical adenocarcinoma CHOL Cholangiocarci","cbCaihhxBJnLiAEx","https://ap.wps.com/l/cbCaihhxBJnLiAEx","pdf",14782245,17,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusion\n# Abbreviations","[{\"question\":\"What is the main purpose of this pan-cancer analysis of ENOPH1?\",\"answer\":\"The study aims to elucidate ENOPH1’s role across multiple cancers by analyzing expression, survival associations, genetic alterations, RNA modifications, and links to immune and genomic features.\"},{\"question\":\"Which platforms and data resources were used to assess ENOPH1 in tumors?\",\"answer\":\"The analysis uses UCSC databases for expression evaluation, GEPIA2 and cBioPortal for survival, genetic alterations, and RNA modification-related assessment, and TIMER2 with R for immune infiltration, TMB, MSI, and HRD.\"},{\"question\":\"What major findings relate ENOPH1 to cancer prognosis and molecular features?\",\"answer\":\"ENOPH1 is upregulated in multiple cancers and high expression correlates with worse overall and disease-specific survival in several tumor types. It also shows correlations with RNA modifications, immune checkpoints/modulators, and genomic instability measures such as TMB, MSI, and HRD.\"}]","Comprehensive pan-cancer analysis of ENOPH1 in human tumors | PDF",1790175768,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/303fb0ac9added5671927b7d85cc88b0.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/103e366c6952e26e21dde86769581ec9.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78eaea44aa5cccfbee8ff6b15a7cc4a7.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b004e94909411832c359d56cf7ecddc.webp",980,1301]